COMMUNITY CLINICAL ONCOLOGY PROGRAM

社区临床肿瘤学计划

• 批准号: 2879177
• 负责人: CHARLES L LOPRINZI
• 金额: $ 16.66万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-15 至 2001-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2879177
• 关键词: alternative medicine; analgesics; anorexia; behavioral /social science research tag; cachexia; cancer pain; chemoprevention; clinical research; clinical trials; community health services; drug addiction; health science research analysis /evaluation; human subject; human therapy evaluation; longitudinal human study; lymphedema; meeting /conference /symposium; neoplasm /cancer; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer therapy; nicotine; oncology; pathology

DESCRIPTION: (Applicant's narrative) The Mayo Clinic through the vehicle of the North Central Cancer Treatment Group (NCCTG) will serve as a primary research base for the following 14 CCOPs: Ann Arbor Regional CCOP, Carle Cancer Center CCOP, Cedar Rapids Oncology Project CCOP, the Duluth CCOP, the Iowa Oncology Research Association, the Merit Care Hospital CCOP, Geisinger CCOP, Missouri Valley Cancer Consortium CCOP, Ochsner CCOP, Illinois Oncology Research Association CCOP, the Arizona Minority CCOP, Scottsdale CCOP, Sioux Community Cancer Consortium CCOP, and the Toledo CCOP. We will also serve as research base for cancer control protocol activity of non-CCOP participants and for the multiple CCOP's outside of our group who contribute to intergroup cancer treatment and cancer control protocols which we lead. We will cooperate with our affiliated CCOPs in planning their program and in conducting appropriate continuing education and workshops. We will provide training and active support for their data managers and oncology nurses. We will coordinate their multi-disciplinary involvement in clinical cancer research protocols. This will include evolving and maintaining standard reporting procedures for surgery, pathology, and radiation therapy. We will hold regular meetings of the CCOPs for review of ongoing research, planning future research, and for related professional activities. We will continue the rigid quality control procedures which have provided so successful in the past, and upgrade these procedures as indicated. We will constantly monitor CCOP performance not only by timely review of patients, data sheets, pathology material, operative reports, and radiation therapy port films, but also by periodic randomly scheduled monitoring site visits. We will work with each CCOP participant to aid in their maturation as clinical investigators. We will assist them in developing new protocols for which they will share leadership, and we will work with them in preparing publications as well as presentations for national and regional meetings. We will make every effort to provide them with justifiable pride in their participation in the National Cancer Program. A high priority over this grant period will be the further expansion of our cancer control efforts into cancer prevention with incorporation of associated basic laboratory support.

描述：（申请人的叙述）通过车辆的梅奥诊所 北中央癌症治疗组（NCCTG）将作为主要 以下14个CCOP的研究基础：Ann Arbor区域CCOP，Carle 癌症中心CCOP，Cedar Rapids肿瘤学项目CCOP，Duluth CCOP， 爱荷华州肿瘤研究协会，杰辛格绩效医院CCOP CCOP，密苏里谷癌症联盟CCOP，Ochsner CCOP，伊利诺伊州 肿瘤研究协会CCOP，亚利桑那州少数民族CCOP，斯科茨代尔 CCOP，SIOUX社区癌症联盟CCOP和Toledo CCOP。 我们将 也是非CCOP癌症控制方案活动的研究基础 参与者和为我们小组的多个CCOP贡献的参与者 我们领导的群体间癌症治疗和癌症控制方案。 我们将与我们的附属CCOPS合作计划他们的计划和 进行适当的继续教育和讲习班。 我们将提供 对其数据经理和肿瘤学护士的培训和积极支持。 我们 将协调其在临床癌中的多学科参与 研究方案。 这将包括不断发展和维护标准 手术，病理和放射治疗的报告程序。 我们将 举行CCOP的定期会议，以审查正在进行的研究，计划 未来的研究以及相关的专业活动。 我们将继续 僵化的质量控制程序在 过去，并按照所示升级这些程序。 我们会不断 不仅通过及时审查患者，数据表，监视CCOP的性能 病理材料，手术报告和放射治疗端口膜，但 还通过定期随机安排的监视现场访问。 我们将工作 每个CCOP参与者都可以作为临床成熟 调查人员。 我们将协助他们制定新协议 他们将分享领导力，我们将与他们合作准备 出版物以及国家和地区会议的演讲。 我们将尽一切努力为他们提供合理的自豪感 参加国家癌症计划。 优先于此 赠款期将是我们癌症控制工作的进一步扩展 结合相关的基本实验室，进入癌症预防 支持。